[go: up one dir, main page]

WO2007002666A3 - Compositions pharmaceutiques et therapeutiques derivees d'une plante garcinia mangostana l - Google Patents

Compositions pharmaceutiques et therapeutiques derivees d'une plante garcinia mangostana l Download PDF

Info

Publication number
WO2007002666A3
WO2007002666A3 PCT/US2006/024968 US2006024968W WO2007002666A3 WO 2007002666 A3 WO2007002666 A3 WO 2007002666A3 US 2006024968 W US2006024968 W US 2006024968W WO 2007002666 A3 WO2007002666 A3 WO 2007002666A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical
plant
therapeutic
derived
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/024968
Other languages
English (en)
Other versions
WO2007002666A2 (fr
Inventor
Alex Moffett
Parag Shah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Renaissance Herbs Inc
Original Assignee
Renaissance Herbs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/281,302 external-priority patent/US20060105069A1/en
Application filed by Renaissance Herbs Inc filed Critical Renaissance Herbs Inc
Publication of WO2007002666A2 publication Critical patent/WO2007002666A2/fr
Publication of WO2007002666A3 publication Critical patent/WO2007002666A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne des compositions pharmaceutiques, thérapeutiques, nutritionnelles, cosmétiques et dermatologiques dérivées du péricarpe (écorce) de Garcinia mangostana L., et de nouveaux procédés d'extraction utilisés pour produire ces compositions. Spécifiquement, l'invention concerne un mélange renfermant environ 0,01 % à environ 80 % d'un extrait du péricarpe (écorce) de mangoustan riche en xanthone, dans de nouvelles combinaisons destinées à des compositions pharmaceutiques, cosmétiques, thérapeutiques ou dermatologiques bénéfiques pour la santé. L'invention concerne en outre de nouveaux procédés d'extraction permettant de produire les nouvelles compositions de l'invention
PCT/US2006/024968 2005-06-22 2006-06-22 Compositions pharmaceutiques et therapeutiques derivees d'une plante garcinia mangostana l Ceased WO2007002666A2 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US69285405P 2005-06-22 2005-06-22
US60/692,854 2005-06-22
US11/281,302 2005-11-16
US11/281,302 US20060105069A1 (en) 2004-11-16 2005-11-16 Pharmaceutical and therapeutic compositions derived from Garcinia mangostana L plant
IN1668/CHE/2005 2005-11-16
IN1668CH2005 2005-11-16

Publications (2)

Publication Number Publication Date
WO2007002666A2 WO2007002666A2 (fr) 2007-01-04
WO2007002666A3 true WO2007002666A3 (fr) 2007-07-12

Family

ID=37595980

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/024968 Ceased WO2007002666A2 (fr) 2005-06-22 2006-06-22 Compositions pharmaceutiques et therapeutiques derivees d'une plante garcinia mangostana l

Country Status (1)

Country Link
WO (1) WO2007002666A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080187502A1 (en) 2007-02-02 2008-08-07 Michelle Garay Assessment and mitigation of oxidative stress in skin
FR2917621B1 (fr) * 2007-06-20 2009-09-18 Centre Nat Rech Scient Utilisation d'heterocycles oxygenes choisis parmi les xanthones et les biflavonoides pour la preparation d'une composition destinee a agir comme agent anti-coccidien
US8853261B2 (en) 2008-01-21 2014-10-07 Laila Nutraceuticals Nutraceutical composition from Garcinia mangostana
ITMI20130619A1 (it) * 2013-04-16 2014-10-17 Variati S R L Nuova associazione cosmetica
CN103393576B (zh) * 2013-08-07 2015-12-23 伽蓝（集团）股份有限公司 一种山竹提取物及其应用
CN106361784B (zh) * 2015-07-24 2020-08-14 山酮新药开发股份有限公司 山竹果果壳萃取物用于治疗皮肤疾病的用途
CN105168478A (zh) * 2015-08-28 2015-12-23 无限极（中国）有限公司 一种护肤品及其制备方法
KR102160798B1 (ko) * 2017-05-23 2020-09-29 동국대학교 산학협력단 망고스틴 추출물 또는 망고스틴 추출물로부터 유래한 잔톤계 화합물을 유효성분으로 포함하는 돼지유행성 설사 예방 또는 치료용 조성물
WO2020091070A1 (fr) * 2018-11-02 2020-05-07 株式会社 資生堂 Agent suppresseur de l'inflammation induite par la lumière ultraviolette comportant un inducteur d'autophagie alternatif
CN113816936B (zh) * 2020-06-19 2023-05-02 广州长峰生物技术有限公司 倒捻子素衍生化合物及其制备方法和应用
CN113620967B (zh) * 2021-07-31 2023-01-06 广州中医药大学(广州中医药研究院) 一种α-倒捻子素衍生物及其制备方法和应用
CN113717144B (zh) * 2021-09-24 2023-04-11 湖南朗林生物资源股份有限公司 一种提取山竹中α-倒捻子素和γ-倒捻子素的方法
AU2021472146B2 (en) * 2021-11-05 2024-12-19 Xantho Biotechnology Co., Ltd Use of mangosteen fruit shell extract in the preparation of a medicament for treating psoriasis
FR3134313B1 (fr) * 2022-04-07 2024-04-05 Fabre Pierre Dermo Cosmetique Association d’un extrait de G arcinia mangostana et d’un jus d’Avena sativa fraiche pour lutter contre l’inflammation induite par C. acnes

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5306486A (en) * 1993-03-01 1994-04-26 Elizabeth Arden Co., Division Of Conopco, Inc. Cosmetic sunscreen composition containing green tea and a sunscreen
US20030138467A1 (en) * 2001-12-27 2003-07-24 Avon Products, Inc. Methods for improving the aesthetic appearance of skin
US20030175237A1 (en) * 2002-02-26 2003-09-18 Bailey William L. Method for the reduction of fasting plasma glucose and hemoglobin AIC levels

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5306486A (en) * 1993-03-01 1994-04-26 Elizabeth Arden Co., Division Of Conopco, Inc. Cosmetic sunscreen composition containing green tea and a sunscreen
US20030138467A1 (en) * 2001-12-27 2003-07-24 Avon Products, Inc. Methods for improving the aesthetic appearance of skin
US20030175237A1 (en) * 2002-02-26 2003-09-18 Bailey William L. Method for the reduction of fasting plasma glucose and hemoglobin AIC levels

Also Published As

Publication number Publication date
WO2007002666A2 (fr) 2007-01-04

Similar Documents

Publication Publication Date Title
WO2007067495A3 (fr) Mésylate de promédicament de lévodopa, compositions comprenant celui-ci, et utilisations de celui-ci
WO2007002666A3 (fr) Compositions pharmaceutiques et therapeutiques derivees d'une plante garcinia mangostana l
WO2007109210A3 (fr) EXTRAITS ET PROCÉDÉS CONTENANT DE l'ESPÈCE CURCUMA
WO2006099169A3 (fr) Nouvelles compositions de liposomes
MY142017A (en) Composition comprising all essential nutrients of a fruit or a plant material with increased stability and bioavailability and process of forming the same
MX2009011869A (es) Aislados antimicrobianos y anti-inflamatorios de extracto de regaliz.
WO2004035629A8 (fr) Taxanes lies de maniere covalente a un acide hyaluronique ou des derives d'acide hyaluronique
WO2009032888A3 (fr) Compositions s'administrant par voie orale, produits et procédés d'utilisation
WO2009019534A3 (fr) Procédés, composés, compositions et véhicules permettant de délivrer l'acide 3-amino-1-propane sulfonique
WO2008030818A3 (fr) Nouvelles compositions de liposomes
WO2008148873A3 (fr) Compositions d'hydroxyproline et leurs utilisations
WO2006034154A3 (fr) Sels de 5-azacytidine
PT1594833E (pt) Derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas
WO2011064401A3 (fr) Extrait de graines de vigna unguiculata et compositions le comprenant
WO2007113291A3 (fr) Compositions alimentaires favorisant la croissance osseuse et le maintien de la santé osseuse et méthodes associées
SG114627A1 (en) Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract
MX2011008261A (es) FORMULACIONES FARMACEUTICAS DE PEPTIDOS INHIBIDORES DE TGF-ß1.
UA92861C2 (ru) Фармацевтическая композиция для лечения депрессии и способ ее получения
WO2004033448A3 (fr) Isolation, purification et synthese de procyanidine b2, et ses utilisations
WO2008135661A3 (fr) Utilisation de la citrulline pour pour le traitement de pathologies liees a une augmentation de la carbonylation des protéines
CY1110401T1 (el) Παραγωγα των 1-φαινυλαλκανοκαρβοξυλικων οξεων για την αντιμετωπιση των νευροεκφυλιστικων νοσων
WO2006078699A3 (fr) Compositions pour soins buccaux derivees de la famille labiatae
GEP20115332B (en) Herbal composition for inflammatory disorders
WO2007048398A3 (fr) Preparation et utilisation d'un agent phytotherapeutique
ATE452120T1 (de) Fettsäure-benzenediol-derivate sowie herstellungs-und verwendungsverfahren dafür

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06774096

Country of ref document: EP

Kind code of ref document: A2